Highlights The COVID-19 pandemic posed a challenge to healthcare institutions, especially ICU personnel, exposing them to physical and mental health risks. Healthcare professionals, including nurses and doctors, faced anxiety and depression due to increased workloads and fear of infection. COVID-19 symptoms and working in both general ICUs and COVID-19 ICUs were identified as significant factors contributing to anxiety and depression among healthcare staff. Women in ICU healthcare roles show a slightly higher susceptibility to anxiety and depression symptoms compared to men. Introduction: The COVID-19 pandemic led to a high prevalence of anxiety and depression among healthcare personnel. Objective: To assess the prevalence and independent risk factors associated with anxiety and depression symptoms among healthcare staff working in Intensive Care Units (ICUs) during the COVID-19 pandemic in Bucaramanga and its metropolitan area. Materials and Methods:   This was an analytical cross-sectional study. Anxiety and depression were measured using the Hopkins Symptom Checklist-25 (HSCL-25). Bivariate and multivariate analyses were conducted using linear regressions to investigate associated factors. Results: A total of 288 people were included in the study. The prevalence of anxiety and depression symptoms was 8.34% (95% CI: 5.41-12.14%). In the bivariate analysis, six factors were associated with depression and anxiety symptoms; however, only three remained in the multivariate analysis: female sex (β=0.085, 95% CI; 0.019 - 0.151), experiencing COVID-19 symptoms in the past 14 days (β= 0.115, 95% CI: 0.024 - 0.205), and having worked in general ICUs and COVID-19 ICUs (β =0.009, 95% CI: 0.025 - 0.173). Discussion: The prevalence of anxiety and depression symptoms was considerably lower than reported in the scientific literature. Conclusions: In the studied population, although the prevalence of depression and anxiety symptoms was low, three independent factors were found to be statistically associated with the presence of these mental symptoms. How to cite this article: Díaz-Mayorga Laura Andrea, Vivas-López Harol Giovanni, Torres Contreras Claudia Consuelo, Rojas Lyda Z, Serrano Norma C, Serrano-García Angie Yarlady, Parra Ortiz Margarita Rosa, Quintero-Lesmes Doris Cristina. COVID-19: Factors associated with symptoms of anxiety and depression in the ICU. Revista Cuidarte. 2025;16(1):e3998.  https://doi.org/10.15649/cuidarte.3998

Highlights Champions are nurses in nursing leadership roles who implement change within an organization. Champions have different characteristics and functions, which vary depending on the needs and goals of the organization. The actions of champions benefit the implementation of evidence-based practice in an organization. Nurse champions need to be identified within the organization to support and encourage their leadership. Nursing practice in an organization result from the leadership processes developed for the profession. It is reflected in the performance of nurses in interprofessional teams and the quality of care they provide to patients1. Evidence-based practice (EBP) refers to decision-making in the development and delivery of health care services according to the best available research evidence, the experience of health care providers, and the values and preferences of patients. The adoption or implementation of EBP by organizations can lead to safer practices, better outcomes for individuals, and lower healthcare costs2. In the literature, "champions" have been identified as determinants and agents of change to ensure adoption within institutions1,3. How to cite this article: Quiroga-Pico Lizeth N, Aceros-Lora Andrea M, Díaz-Castañeda Tatiana M, Rojas Lyda Z. Nurse Champions: Transforming Evidence-Based Practice. Revista Cuidarte. 2024;15(2):e3745.  https://doi.org/10.15649/cuidarte.3745

Introduction: Hypertension and diabetes mellitus are chronic diseases imposing a significant economic and social burden. Managing these diseases requires lifestyle changes, adherence to drug treatment and effective disease monitoring. Measuring compliance usually focuses on drug treatment, leaving aside the comprehensive approach which involves different key recommendations for appropriate control of these diseases. Objective: To determine the construct and reproducibility validity of the Nursing Outcomes Classification label “Therapeutic behavior: illness or injury (1609)” to measure adherence to the therapeutic regimen in people with hypertension and type 2 diabetes mellitus. Materials and Methods: A cross-sectional study was conducted among 500 users of cardiovascular risk reduction programs in Bucaramanga, Colombia. An instrument was designed to measure adherence to treatment based on the Nursing Outcomes Classification taxonomy, current recommendations from scientific literature and researchers experience. Construct validity was assessed using a principal component factor analysis based on the Rasch model. Reproducibility was validated using the intraclass correlation coefficient in 100 users. Results: A 13-item instrument comprising 5 indicators of the Nursing Outcome Classification label (1609) was developed, which explained 67.62% of the total variation, fitting the Rasch model (unidimensionality of the adherence construct). Reproducibility was 0.63 (95% CI 0.46-0.75). Conclusions: Evidence was found for the construct validity of the instrument operationalizing the Nursing Outcomes Classification label (1906) for the measurement of adherence to the therapeutic regimen in patients with hypertension and diabetes. How to cite this article: Romero Guevara  Sandra Lucrecia, Parra Dora Inés, Roa Díaz Zayne Milena, Rojas Lyda Z. Validación de un instrumento para medir la adherencia al tratamiento en hipertensión y diabetes. Revista Cuidarte. 2020;11(3):e1062. http://dx.doi.org/10.15649/cuidarte.1062